Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Non-Diabetic Chronic Kidney Disease

media

posted on 2021-04-12, 14:57 authored by Adis Journals on behalf of, Akira Mima

<p><strong>Article full text</strong></p> <p> </p> <p><br></p> <p> </p> <p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p> <p>© The authors, CC-BY-NC 2021.</p>

History

Related Materials

1.
URL - References https://link.springer.com/article/10.1007/s12325-021-01735-5
2.
DOI - Is supplement to Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Non-Diabetic Chronic Kidney Disease

Usage metrics

Advances in Therapy

Categories

Medicine

Keywords

Sodium-glucose cotransporter-2 (SGLT2) inhibitors Chronic kidney disease (CKD)Tubuloglomerular feedback (TGF)Inflammation Oxidative stress Hypoxia inducible factor (HIF)

Licence

Exports